Evidence-based·Updated November 20, 2026·How we grade evidence

hCG (Human Chorionic Gonadotropin)

MedicationFertility hormone injection (prescription)

hCG is a prescription hormone injection used in fertility treatment, in boys with undescended testicles, and in males with low testosterone from a pituitary cause. Combined with FSH it restores sperm production in most men with that condition, though often below normal levels. It does not help weight loss: its labels, FDA, a meta-analysis and a placebo-controlled trial agree, and "homeopathic" hCG drops are illegal. Its use with testosterone therapy is off-label and supported mainly by small studies of hormone levels and semen counts.

Taking hCG (Human Chorionic Gonadotropin) with other supplements or medications?Check your whole list for interactions. Free, no account.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Women in supervised fertility treatment, males with hypogonadotropic hypogonadism (including those trying to father a child), and selected boys with undescended testicles, under a specialist

Common dosing range

Set by your prescriber. Labeled regimens vary by use: for example 5,000 to 10,000 USP units once, one day after the last dose of other fertility hormones, for ovulation; 500 to 4,000 USP units two or three times a week for months in males with hypogonadotropic hypogonadism

When to expect effects

Ovulation: within days of the trigger injection. Sperm production in hypogonadotropic hypogonadism: on average about 12 months in pooled studies

Watch out for

No boxed warning. In women: ovarian hyperstimulation syndrome (OHSS), blood clots, multiple pregnancy and ovarian torsion. In boys: early puberty. Allergic reactions including anaphylaxis. Contraindicated with prostate or other androgen-dependent cancers and early puberty (Novarel and generic labels); the Novarel label says it may cause fetal harm in pregnancy, and the Pregnyl label says it is not indicated in pregnancy. Not approved or effective for weight loss; over-the-counter hCG products are illegal

What is it

Human chorionic gonadotropin (hCG) is a hormone made by the placenta in pregnancy. As a medicine it is a prescription injection, approved by FDA. Novarel (5,000 and 10,000 USP unit vials), Pregnyl (10,000 USP units) and a generic chorionic gonadotropin (10,000 USP units, Fresenius Kabi) are purified from the urine of pregnant women and injected into a muscle; Ovidrel (choriogonadotropin alfa) is a lab-made version injected under the skin for fertility treatment. The urinary hCG labels approve three uses: undescended testicles in boys before puberty when nothing physically blocks their descent, selected cases of low testosterone caused by a pituitary problem (hypogonadotropic hypogonadism) in males, and triggering ovulation in women whose ovaries do not release eggs, after treatment with other fertility hormones. The same labels state in capital letters that hCG has not been shown to be an effective addition to obesity treatment. FDA says there are no FDA-approved hCG products for weight loss and that hCG is not approved for use without a prescription. Its use alongside testosterone therapy in men is off-label.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You are in fertility treatment and your reproductive specialist uses hCG to trigger ovulation, with ultrasound and hormone monitoring
You are a man with low testosterone from a pituitary or hypothalamic cause and want to father a child, and an endocrinologist or urologist prescribes gonadotropins
You take testosterone therapy, want to preserve fertility, and a specialist explains that adding hCG is an off-label choice supported mainly by small studies

Probably skip if…

You want to lose weight: the labels say there is no substantial evidence it adds weight loss beyond calorie restriction, and FDA says no hCG product is approved for weight loss
You are offered "homeopathic" hCG drops, pellets or sprays: FDA says all drug products claiming to include homeopathic hCG are illegally marketed
You have prostate cancer or another androgen-dependent tumor, or a past allergic reaction to hCG (contraindications on the labels), or you are pregnant (the Novarel label says hCG may cause fetal harm, and the Pregnyl label says it is not indicated in pregnancy)
You would use it without a prescription or monitoring: FDA says hCG is not approved for use without a prescription for any purpose

Evidence at a glance

triggering final egg maturation in IVF and ICSI fertility treatment

Good Evidence
Effect
In fresh cycles with a woman's own eggs: higher live birth rate than a GnRH agonist trigger (OR 0.47 for agonist versus hCG), with more OHSS
Best fit
Women in supervised IVF or ICSI cycles
Time
Egg retrieval or ovulation follows within days of the injection

weight loss with a very low-calorie diet (the "hCG diet")

Good Evidence
Effect
No difference from placebo in weight loss, hunger or fat distribution
Best fit
None shown
Time
No benefit seen over 6 weeks

sperm production in men with hypogonadotropic hypogonadism

Limited Evidence
Effect
Sperm production restored in about 74% to 78% of men; mean concentration about 10 to 12 million per mL
Best fit
Men with low LH and FSH from a pituitary or hypothalamic cause, especially with onset after puberty, treated with hCG plus FSH
Time
About 12 to 18 months

undescended testicles (cryptorchidism) in boys

Limited Evidence
Effect
About 24% complete descent in one meta-analysis; not better than placebo in another
Best fit
Selected boys, as decided by a pediatric urologist
Time
Weeks, over a course of injections

preserving testicular function in men on testosterone therapy (off-label)

Limited Evidence
Effect
Testicular testosterone kept near baseline with 250 to 500 IU every other day for 3 weeks
Best fit
Men on testosterone therapy who want to keep fertility, under a specialist
Time
Weeks for hormone levels; months for semen measures

Evidence for 5 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

triggering final egg maturation in IVF and ICSI fertility treatment

Disease adjunct
Good Evidence

A 2014 Cochrane review of 17 randomized trials compared a GnRH agonist trigger with an hCG trigger in IVF cycles using a GnRH antagonist. In fresh cycles using a woman's own eggs, the agonist gave a lower live birth rate than hCG (odds ratio 0.47, 95% CI 0.31 to 0.70; 5 trials, 532 women; moderate-quality evidence): for a woman with a 31% chance of live birth with hCG, the chance with the agonist would be 12% to 24%. But hCG carried more OHSS: for a 5% risk with hCG, the risk with the agonist would be between nil and 2% (odds ratio 0.15; moderate-quality evidence). In donor-recipient cycles, the review found no evidence of a difference in live birth (1 trial, 212 women), while OHSS was again lower with the agonist. A 2016 Cochrane review of 18 trials (2,952 women) found no clear difference in ongoing pregnancy or live birth between lab-made and urinary hCG (odds ratio 1.15, 95% CI 0.89 to 1.49; 7 trials, 1,136 women; moderate-quality evidence), and no difference in OHSS; pharmaceutical companies funded 9 of the 18 trials.

Effect size
In fresh cycles with a woman's own eggs: higher live birth rate than a GnRH agonist trigger (OR 0.47 for agonist versus hCG), with more OHSS
Time to effect
Egg retrieval or ovulation follows within days of the injection
Best fit
Women in supervised IVF or ICSI cycles
Less likely
Women who will not have a fresh embryo transfer, egg donors, and women freezing eggs, for whom the review said an agonist trigger could be useful because it lowered OHSS

Bottom line: In fresh IVF cycles using a woman's own eggs, an hCG trigger gives more live births than a GnRH agonist trigger but more OHSS; no difference was found between urinary and lab-made hCG.

weight loss with a very low-calorie diet (the "hCG diet")

No benefit found
Good Evidence

A 1995 meta-analysis of 8 controlled and 16 uncontrolled trials of hCG with the Simeons very low-calorie diet found most studies were of poor quality; of the 12 studies scoring 50 or more points for quality (all controlled), only one reported hCG as a useful adjunct. The authors concluded that hCG does not bring about weight loss or fat redistribution, reduce hunger, or improve well-being. In a double-blind trial, 40 women with a BMI over 30 followed the same 5,000 kJ a day diet and received daily injections of hCG or saline 6 days a week for 6 weeks; those on hCG showed no advantage over placebo on any measure, including weight, hunger and body circumferences. Weight loss in these programs comes from the calorie restriction.

Effect size
No difference from placebo in weight loss, hunger or fat distribution
Time to effect
No benefit seen over 6 weeks
Best fit
None shown
Less likely
Anyone trying to lose weight

Bottom line: hCG does not add weight loss beyond the very low-calorie diet it is sold with.

sperm production in men with hypogonadotropic hypogonadism

Biomarker support
Limited Evidence

A 2025 meta-analysis of 41 studies (1,673 men with gonadotropin deficiency, mean age 25) found that after a median of 18 months of gonadotropin treatment, the average sperm concentration reached 11.6 million per mL. Any sperm appeared in 78% of men, more than 5 million per mL in 36% and more than 20 million per mL in 15%. Combined hCG and FSH gave more sperm than hCG alone, while testosterone levels and testicular size rose similarly with both. A 2026 meta-analysis of 50 studies (1,583 men with azoospermia) found sperm production restored in 74% after a mean of 11.8 months, and a pregnancy rate of 52% among couples wanting a child; most included studies were of poor methodological quality. An earlier meta-analysis found a 75% success rate and that previous testosterone therapy did not affect the result.

Effect size
Sperm production restored in about 74% to 78% of men; mean concentration about 10 to 12 million per mL
Time to effect
About 12 to 18 months
Best fit
Men with low LH and FSH from a pituitary or hypothalamic cause, especially with onset after puberty, treated with hCG plus FSH
Less likely
Men whose low testosterone comes from the testes themselves (primary hypogonadism), who were not the target of these studies

Bottom line: hCG, especially combined with FSH, restores sperm production in most men with pituitary-related hypogonadism, though counts often stay below normal.

undescended testicles (cryptorchidism) in boys

Disease adjunct
Limited Evidence

The evidence is weak and conflicting. A 2016 meta-analysis of 13 randomized trials found that hCG raised the rate of complete testicular descent compared with control, with a success rate of 24%, an effect seen in boys with both testicles undescended but not with one; the authors said hormones cannot be recommended for everyone because of low success rates and possible long-term harms. A 2018 meta-analysis of 7 low-quality trials found hCG no more effective than placebo (risk ratio 7.74, 95% CI 0.14 to 425.72; 2 trials, 31 boys). The 2014 American Urological Association guideline states that hormonal therapy is not recommended and that orchiopexy (surgery) is the most successful treatment. The labels also note that in most cases the response to hCG is temporary.

Effect size
About 24% complete descent in one meta-analysis; not better than placebo in another
Time to effect
Weeks, over a course of injections
Best fit
Selected boys, as decided by a pediatric urologist
Less likely
Boys with one undescended testicle, and those for whom surgery is planned

Bottom line: hCG moves undescended testicles down in only a minority of boys, often temporarily, and current US guidance prefers surgery.

Evidence is mixed

One meta-analysis of 13 trials found a modest benefit (24% success), while another of 7 trials found no benefit over placebo, and the AUA guideline does not recommend hormonal therapy.

preserving testicular function in men on testosterone therapy (off-label)

Biomarker support
Limited Evidence

This is not an FDA-approved use. In a 3-week randomized study, 29 healthy men received 200 mg testosterone enanthate weekly with saline or hCG 125, 250 or 500 IU every other day. LH and FSH fell to 5% and 3% of baseline, and with testosterone plus saline, testosterone inside the testes fell by 94%. After treatment, testosterone inside the testes was 25% below baseline with 125 IU, 7% below with 250 IU and 26% above with 500 IU. In a retrospective review of 26 hypogonadal men (mean age 35.9) on testosterone plus hCG 500 IU every other day, followed for a mean of 6.2 months, semen measures did not change, no man became azoospermic, and 9 of the 26 contributed to a pregnancy. Neither study had a group on testosterone alone followed for fertility outcomes, and long-term safety was not studied.

Effect size
Testicular testosterone kept near baseline with 250 to 500 IU every other day for 3 weeks
Time to effect
Weeks for hormone levels; months for semen measures
Best fit
Men on testosterone therapy who want to keep fertility, under a specialist
Less likely
Men seeking hCG as a general testosterone booster, which these studies did not test

Bottom line: Small studies suggest low-dose hCG keeps the testes working during testosterone therapy, but this off-label use lacks controlled fertility trials.

How it works

hCG acts almost exactly like luteinizing hormone (LH), the pituitary hormone that tells the testes and ovaries to work, with a small amount of follicle-stimulating hormone (FSH)-like activity. In males it stimulates the Leydig cells of the testes to make testosterone, which drives male puberty changes and can help an undescended testicle move down; the labels note that in most boys this descent is temporary. In women it can stand in for the mid-cycle LH surge that releases a mature egg, and it supports the corpus luteum, which makes progesterone. The labels state that hCG has no known effect on fat mobilization, appetite, hunger or where body fat is stored. In men taking testosterone, the added hormone shuts down the body's own LH and FSH, so the testes make less testosterone of their own and sperm production can fall. Low-dose hCG is sometimes added off-label to keep the testes working. hCG can also cross-react in laboratory tests for gonadotropins, especially LH, so the labels ask that the lab be told when a patient is on hCG.

How to take it

1. Typical dose
Your prescriber sets the dose, which depends on the use, age and weight. Regimens listed on the Novarel and Pregnyl labels: for undescended testicles in boys (usually ages 4 to 9), for example 4,000 USP units three times a week for 3 weeks, or 5,000 USP units every second day for 4 injections, among other schedules; for hypogonadotropic hypogonadism in males, 500 to 1,000 USP units three times a week for 3 weeks then twice a week for 3 weeks, or 4,000 USP units three times a week for 6 to 9 months, then 2,000 USP units three times a week for another 3 months; for ovulation induction, 5,000 to 10,000 USP units one day after the last dose of other fertility hormones. Novarel, Pregnyl and generic chorionic gonadotropin are labeled as injections into a muscle.
2. Higher studied dose
No dose is approved for use with testosterone therapy. In a 3-week study in healthy men given testosterone, hCG was studied at 125, 250 or 500 IU every other day; a retrospective clinic series used 500 IU every other day.
3. Timing
On the schedule your prescriber sets; for ovulation, the labels time the injection one day after the last dose of the other fertility hormones.
4. With food
It is an injection, so food does not matter; the labels give no food instructions.
5. Split dosing
Not applicable; doses are single injections on a set schedule.
6. How long to try
From a single trigger injection in fertility treatment to many months in males with hypogonadotropic hypogonadism. Mixed vials are stored in the refrigerator: Novarel is used within 30 days of mixing, Pregnyl within 60 days.

What to track

Women: severe pelvic or belly pain, swelling, nausea, vomiting, diarrhea, rapid weight gain, shortness of breath or passing little urine, which the Pregnyl label lists as signs of OHSS; it can peak 7 to 10 days after treatment
Women: the ultrasound scans and estradiol blood tests your fertility team orders to watch ovarian response
Boys treated for undescended testicles: signs of early puberty, which the labels say mean treatment should stop
Males: breast enlargement, swelling from fluid retention, and the semen and hormone tests your specialist orders
Anyone: hives, rash, swelling of the face or throat, or trouble breathing, which can mean an allergic reaction and need emergency care
Lab tests: tell the lab you are on hCG if gonadotropin (LH) levels are tested, because hCG can cross-react in those tests

Bottom line: A specialist-supervised injection whose dose and schedule your prescriber sets; it is not a weight-loss or over-the-counter product.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Headache, irritability, restlessness, depression and tirednessFluid retention and swelling (edema)Pain, bruising, redness, swelling or itching at the injection siteBreast enlargement in males (gynecomastia), which the Pregnyl label says may occur sporadically, and painful breasts in womenIn women, mild OHSS with belly pain, nausea and diarrhea, and mild to moderate ovarian enlargement or cysts

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the contraindications section of the Novarel label says hCG may cause fetal harm when given to a pregnant woman; in mice, combined hCG and pregnant mare's serum caused high rates of birth defects, and whether this applies to humans is not known. The Pregnyl label says it is not indicated in pregnancy, may be used for luteal phase support but is stopped once pregnancy is confirmed, and that there are no data on hCG use in pregnancy. Breastfeeding: both labels say it is not known whether hCG passes into human milk and that caution should be used in a nursing woman; the Pregnyl label adds that the benefits of breastfeeding should be weighed with the mother's need for the drug. Talk with your doctor about pregnancy plans and feeding your baby.

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Prescription only: Novarel (Ferring; 5,000 or 10,000 USP unit vials), Pregnyl (Organon; 10,000 USP units) or generic chorionic gonadotropin (Fresenius Kabi; 10,000 USP units), each a powder supplied with a 10 mL vial of diluent preserved with benzyl alcohol and labeled for intramuscular use
Ovidrel (choriogonadotropin alfa, EMD Serono) is a prefilled syringe injected under the skin, labeled for fertility treatment
After mixing, the solution is kept in the refrigerator: Novarel is used within 30 days, Pregnyl within 60 days; do not freeze
Labeled in USP units, with an FDA-approved prescribing information leaflet; dispensed by a pharmacy with a prescription in your name

Be skeptical of…

"Homeopathic" hCG drops, pellets or sprays for weight loss: FDA says all drug products claiming to include homeopathic hCG are illegally marketed
"Resets your metabolism" or "lose 20 to 30 pounds in 30 to 40 days": FDA quotes these as typical hCG diet claims and says any loss comes from severe calorie restriction, not hCG
"Curbs hunger on a 500-calorie diet" or "reshapes where you store fat": the labels say there is no substantial evidence for either
"Over-the-counter hCG": FDA says hCG is not approved for use without a prescription for any purpose
"hCG is a safe testosterone booster for any man": its approved male use is hypogonadotropic hypogonadism, and use alongside testosterone therapy is off-label
hCG sold online without a prescription: FDA-approved hCG products are prescription injections only, so anything else is not an approved product and its content and sterility are unverified

Frequently asked questions

Does hCG help with weight loss?⌄

No. The prescription labels state that hCG has not been shown to be effective in treating obesity and that there is no substantial evidence it adds weight loss beyond calorie restriction, changes fat distribution, or reduces hunger. A meta-analysis and a 6-week placebo-controlled trial in 40 women found no benefit. FDA says any loss on hCG diets comes from the severe calorie restriction.

Are hCG diet drops legal?⌄

No. FDA says there are no FDA-approved hCG products for weight loss, that hCG is not approved for use without a prescription, and that all drug products claiming to include "homeopathic" hCG are illegally marketed. FDA and the FTC sent warning letters to sellers of such drops, pellets and sprays.

Why do some men on testosterone therapy use hCG?⌄

Testosterone therapy shuts down the hormones that tell the testes to make sperm and their own testosterone. Small studies found low-dose hCG kept testicular testosterone near normal for 3 weeks and kept semen measures stable in 26 men over about 6 months. This use is off-label and has no large controlled trials, so it is a decision for you and a specialist.

What is hCG approved for?⌄

The labels approve it for undescended testicles in boys before puberty when nothing physically blocks descent, selected cases of low testosterone caused by a pituitary problem in males, and triggering ovulation in women who do not ovulate, after other fertility hormones. Ovidrel, a lab-made form, is approved for fertility treatment including IVF.

Can I take hCG with my supplements or other medicines?⌄

The hCG labels list no drug interactions, there are no studies of hCG with supplements, and our database lists no supplement or food interactions for it. The labels do say hCG can interfere with laboratory tests for LH, so tell the lab you are on it. Ask your doctor or pharmacist to check your full list, including supplements.

Is hCG safe for women in fertility treatment?⌄

It is widely used under supervision, but the labels warn of ovarian hyperstimulation syndrome, which can be severe, blood clots, multiple pregnancy and ovarian torsion. Your fertility team monitors you with ultrasound and blood tests, and the Pregnyl label says women should be watched for OHSS for at least two weeks after the hCG dose.

References by claim

sperm production in men with hypogonadotropic hypogonadism

Muir et al., 2025 · PubMed (2025) link

Huijben et al., 2026 · PMC (2026) link

Rastrelli et al., 2014 · PubMed (2014) link

triggering final egg maturation in IVF and ICSI fertility treatment

Youssef et al., 2014 · PMC (2014) link

Youssef et al., 2016 · PMC (2016) link

undescended testicles (cryptorchidism) in boys

Bu et al., 2016 · PubMed (2016) link

Wei et al., 2018 · PubMed (2018) link

Kolon et al., 2014 · PubMed (2014) link

weight loss with a very low-calorie diet (the "hCG diet")

Lijesen et al., 1995 · PMC (1995) link

Bosch et al., 1990 · PubMed (1990) link

preserving testicular function in men on testosterone therapy (off-label)

Coviello et al., 2005 · PubMed (2005) link

Hsieh et al., 2013 · PubMed (2013) link

Safety

Pregnyl (chorionic gonadotropin) prescribing information · DailyMed (FDA label) link

Novarel (chorionic gonadotropin) prescribing information · DailyMed (FDA label) link

Questions and Answers on HCG Products for Weight Loss · FDA link

Avoid Dangerous HCG Diet Products (FDA Consumer Update) · FDA link

Sanches et al., 2014 · PubMed (2014) link

Chorionic gonadotropin for injection prescribing information (Fresenius Kabi) · DailyMed (FDA label) link

Track hCG (Human Chorionic Gonadotropin) with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 20, 2026·Evidence current as of Nov 20, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.